Dr. Usama Ahmad holds a specialization in Pharmaceutics from Amity University, Lucknow, India. He received his Ph.D. degree from the Integral University on his work titled ‘Development and evaluation of silymarin nanoformulation for hepatic carcinoma’. Currently, he’s working as an Assistant Professor of Pharmaceutics in the Faculty of Pharmacy, Integral University. He has been teaching Pharm.D, B.Pharm, and M.Pharm students and conducting research in the novel drug delivery domain. From 2013 to 2014 he worked on a research project funded by SERB-DST, Government of India. He has a rich publication record with more than 17 original articles published in reputed journals, 1 edited book with IntechOpen, 2 book chapters (1 with McGraw Hill Publishers and other with IntechOpen), and a number of scientific articles published in ‘Ingredients South Asia Magazine’ and ‘QualPharma Magazine’. He is a member of the American Association for Cancer Research, Commonwealth Pharmacist Association, and the British Society for Nanomedicine. Dr. Ahmad’s research focus is on the development of nanoformulations to facilitate the delivery of drugs that aim to provide practical solutions to current healthcare problems.